SectorPharmaceutical
Established Date--
Listing Date14/12/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees13
Fiscal Year Ends31/12
Security TypeCommon stock
Office address29 Emmons Drive, Suite B-10, Princeton, NJ 08540
Business
IntroductionFounded in 1987, Soligenix, Inc., is a clinical-stage biopharmaceutical company focused on the development of products for the treatment of life-threatening side effects (still an unmet medical need) arising from the treatment of cancer and serious gastrointestinal diseases, as well as the development of a variety of biodefense vaccines and therapies.
